cyclopentane has been researched along with Encephalopathy, Toxic in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (50.00) | 29.6817 |
2010's | 2 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Furuta, K; Hirata, Y; Kiuchi, K; Oh-Hashi, K; Shibata, S; Ueda, H | 1 |
Alam, M; Danysz, W; Dekundy, A; Schmidt, WJ | 1 |
Apland, JP; Aroniadou-Anderjaska, V; Braga, MF; Ferrara, TM; Figueiredo, TH; Pidoplichko, V; Qashu, F; Stevens, D | 1 |
Carelli, V; Costa, N; De Vita, D; Liberatore, F; Marra, R; Rispoli, V; Rotiroti, D; Scipione, L; Tirassa, P | 1 |
4 other study(ies) available for cyclopentane and Encephalopathy, Toxic
Article | Year |
---|---|
Prevention of oxytosis-induced c-Raf down-regulation by (arylthio)cyclopentenone prostaglandins is neuroprotective.
Topics: Animals; Antioxidants; Cell Line; Cell Survival; Cyclopentanes; Cytoprotection; Dose-Response Relationship, Drug; Down-Regulation; Extracellular Signal-Regulated MAP Kinases; Glutamic Acid; Glutathione; Hippocampus; MAP Kinase Kinase Kinases; Mice; Neurons; Neuroprotective Agents; Neurotoxicity Syndromes; Oxidative Stress; Phosphorylation; Prostaglandins; Protein Binding; Proto-Oncogene Proteins c-raf; Signal Transduction | 2017 |
Effects of glutamate and alpha2-noradrenergic receptor antagonists on the development of neurotoxicity produced by chronic rotenone in rats.
Topics: Adrenergic alpha-2 Receptor Antagonists; Adrenergic alpha-Antagonists; Animals; Basal Ganglia; Behavior, Animal; Catalepsy; Cyclopentanes; Disease Models, Animal; Dopamine; Excitatory Amino Acid Antagonists; Hypokinesia; Idazoxan; Male; Motor Activity; Muscle Rigidity; Neuroprotective Agents; Neurotoxicity Syndromes; Parkinsonian Disorders; Pyridines; Rats; Rats, Sprague-Dawley; Receptor, Metabotropic Glutamate 5; Receptors, Adrenergic, alpha-2; Receptors, Metabotropic Glutamate; Receptors, N-Methyl-D-Aspartate; Rotenone; Serotonin; Substantia Nigra; Time Factors | 2009 |
Neuroprotective efficacy of caramiphen against soman and mechanisms of its action.
Topics: Animals; Behavior, Animal; Brain; Cell Count; Chemical Warfare Agents; Cyclopentanes; Dose-Response Relationship, Drug; Male; Neurons; Neuroprotective Agents; Neurotoxicity Syndromes; Patch-Clamp Techniques; Rats; Rats, Sprague-Dawley; Receptors, AMPA; Receptors, GABA-A; Receptors, N-Methyl-D-Aspartate; Seizures; Soman; Synaptic Potentials | 2011 |
Choline pivaloyl ester enhances brain expression of both nerve growth factor and high-affinity receptor TrkA, and reverses memory and cognitive deficits, in rats with excitotoxic lesion of nucleus basalis magnocellularis.
Topics: Animals; Basal Nucleus of Meynert; Behavior, Animal; Brain; Choline O-Acetyltransferase; Cognition Disorders; Cyclopentanes; Electroencephalography; Functional Laterality; Gene Expression Regulation; Male; Maze Learning; Memory Disorders; Nerve Growth Factor; Neuropsychological Tests; Neurotoxicity Syndromes; Rats; Rats, Wistar; Reaction Time; Receptor, trkA; Time Factors | 2008 |